CN1212162A - High efficiency ointment for curing beri-beri (tinea pedis) - Google Patents
High efficiency ointment for curing beri-beri (tinea pedis) Download PDFInfo
- Publication number
- CN1212162A CN1212162A CN98110520A CN98110520A CN1212162A CN 1212162 A CN1212162 A CN 1212162A CN 98110520 A CN98110520 A CN 98110520A CN 98110520 A CN98110520 A CN 98110520A CN 1212162 A CN1212162 A CN 1212162A
- Authority
- CN
- China
- Prior art keywords
- ointment
- tinea pedis
- thin
- beriberi
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010047601 Vitamin B1 deficiency Diseases 0.000 title claims abstract description 32
- 208000002894 beriberi Diseases 0.000 title claims abstract description 32
- 201000004647 tinea pedis Diseases 0.000 title claims abstract description 26
- 239000002674 ointment Substances 0.000 title claims abstract description 17
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 16
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229960004889 salicylic acid Drugs 0.000 claims abstract description 9
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims abstract description 8
- 230000001737 promoting effect Effects 0.000 claims abstract description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 3
- 239000003814 drug Substances 0.000 claims description 48
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 15
- 229940079593 drug Drugs 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000005303 weighing Methods 0.000 claims description 8
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 7
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 7
- 229920002261 Corn starch Polymers 0.000 claims description 7
- 229940025250 camphora Drugs 0.000 claims description 7
- 239000010238 camphora Substances 0.000 claims description 7
- 239000008120 corn starch Substances 0.000 claims description 7
- 229940099112 cornstarch Drugs 0.000 claims description 7
- 239000006071 cream Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 235000011837 pasties Nutrition 0.000 claims description 7
- 238000010025 steaming Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 241001161070 Calomela Species 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 239000008280 blood Substances 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 4
- 231100000614 poison Toxicity 0.000 claims description 4
- 230000003213 activating effect Effects 0.000 claims description 3
- 238000012216 screening Methods 0.000 claims description 3
- 230000017423 tissue regeneration Effects 0.000 claims description 3
- 239000003440 toxic substance Substances 0.000 claims description 3
- 230000008595 infiltration Effects 0.000 claims description 2
- 238000001764 infiltration Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000007670 refining Methods 0.000 claims description 2
- 239000008188 pellet Substances 0.000 claims 1
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 208000002474 Tinea Diseases 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 1
- 241000130764 Tinea Species 0.000 abstract 1
- 229940037003 alum Drugs 0.000 abstract 1
- 230000017531 blood circulation Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 11
- 210000002683 foot Anatomy 0.000 description 7
- 230000003628 erosive effect Effects 0.000 description 5
- 238000001816 cooling Methods 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical group [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 206010067482 No adverse event Diseases 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 239000002316 fumigant Substances 0.000 description 2
- 230000001473 noxious effect Effects 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- MCCACAIVAXEFAL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole;nitric acid Chemical compound O[N+]([O-])=O.ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 MCCACAIVAXEFAL-UHFFFAOYSA-N 0.000 description 1
- OCAPBUJLXMYKEJ-UHFFFAOYSA-N 1-[biphenyl-4-yl(phenyl)methyl]imidazole Chemical compound C1=NC=CN1C(C=1C=CC(=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 OCAPBUJLXMYKEJ-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010005913 Body tinea Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 206010067130 Spastic diplegia Diseases 0.000 description 1
- 208000007712 Tinea Versicolor Diseases 0.000 description 1
- 201000010618 Tinea cruris Diseases 0.000 description 1
- 206010067197 Tinea manuum Diseases 0.000 description 1
- 206010056131 Tinea versicolour Diseases 0.000 description 1
- 229960002206 bifonazole Drugs 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 206010008129 cerebral palsy Diseases 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229960005040 miconazole nitrate Drugs 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 1
- 229960003712 propranolol Drugs 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
- 229960002722 terbinafine Drugs 0.000 description 1
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 201000003875 tinea corporis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The high-effective fine ointment for curing beriberi and tinea pedis is made up by using the Chinese medicinal materials with the functions of dispelling wind-damp, moistening, clearing away heat and removing toxic material, sterilizing and disinfection, promoting blood circulation and engendering flesh as raw material. Its preparation process includes the following steps: firstly, grinding seven solid medicinal materials of Danyu, calcined oyster shell and calcined alum, etc. into fine powder; uniformly mixing the fine powder with salicylic acid powder and talcum powder, and adding oil agent and mixing them uniformly, then adding special-made diluent medicinal liquor to make them into the invented paste-like ointment product. Said ointment not only possesses high cure rate for tinea pedis, but also can cure other tineas.
Description
The invention belongs to a kind of beriberi (tinea pedis) medicine, thin ointment in particularly a kind of efficient beriberi (tinea pedis).
Beriberi (tinea pedis) is caused by endogenous cause of ill and exopathogenic factor, endogenous cause of ill is to be made a bet by damp-heat in the spleen and stomach to be stranded in foot and must not to declare logical and due to the intrusive viruses, pathogenic bacteria, sick worm, exopathogenic factor is that wind-engaging, wet, heat, severe pathogenic cold are attacked within the foot skin, corrosion failure skin cell tissue, must not declare logical, body fluid can not the nutrition skin lose because of QI and blood and drive outer function, thereby due to virus, pathogenic bacteria, sick worm invades.Beriberi (tinea pedis) disease though be little disease, is unlikely threat to life, and it brings pruritus misery unbearably not ignore to the patient.Because the raising of people's living standard, staple food has changed thin smart powder of rice and meat into, egg, milk, so imapirment of the spleen and stomach and produce damp-heat in the spleen and stomach and make a bet along meridians and be stranded in foot and must not declare logical very easily, reduce and drive outer function, thereby very easily produce beriberi (tinea pedis), secondly, atmospheric pollution, water resource pollution, the plastics footgears of breathability extreme difference etc. have created good condition for the beriberi virus attack, therefore, at present the beriberi rate of falling ill is higher, and from beriberi (tinea pedis) condition of illness, the overwhelming majority is phosphorus bits types, erosive type, the blister type coexists simultaneously, interdependent symbiosis, only a few patient is a unitary type, so in therapeutic process, to adopt comprehensive Drug therapy for well.Current, common medicine divides Western medicine and Chinese medicine two big classes, Western medicine has terbinafine HCl ointment, inspire confidence in fine jade (bifonazole) emulsifiable paste, the white ointment of the strong treatment of Pinocine, miconazole nitrate (daktarin) frost etc., above western medicine beriberi (tinea pedis) has played certain effect, but small number of patients is often had side effects, as calcination appears, pruritus, fish is split, irritated, untoward reaction such as contact dermatitis, simultaneously, use western medicine, often can only be effective to one type beriberi disease, and three types of (phosphorus bits types, erosive type, the blister type) simultaneous patient unsatisfactory curative effect then, the medicine that also has is then clear and definite indicates certain situation forbidding.The Chinese medicine of treatment beriberi (tinea pedis) has Compound Flavescent Sophora and Salicylic Acid Powder, JIAOXIAN YICIJING, skin healthy and free from worry etc., though this type of medicine has improved curative effect, but use and convenient inadequately, as JIAOXIAN YICIJING, the plastic foot cover need be enclosed within on the foot during use, taking liquid is poured in the footmuff, uses inconvenience, and the appearance side effect that has.Utilize several treatment by Chinese herbs beriberi that several method is also arranged, as fumigant method, washing method, powder method, the fumigant method is only better to beriberi (tinea pedis) effect due to pathogenic wind toxic, the severe pathogenic cold, and beriberi (tinea pedis) effect due to the noxious dampness is relatively poor, beriberi (tinea pedis) forbidding due to the burning hot poison; Washing method, with the Chinese medicine hot water injection affected part of clearing up internal heat by using drugs of bitter in taste and cold in nature dampness, therapeutic effect is better, but then can't kill the toadstool worm skin depths of hiding, better to erosive type beriberi (tinea pedis) effect due to the noxious dampness, relatively poor to beriberi (tinea pedis) effect due to pyretic toxicity, the pathogenic wind toxic; The powder method, be with eliminating dampness by diuresis dispel the wind, the Chinese medicine of heat-clearing and toxic substances removing, blood activating and promoting tissue regeneration is processed into powder and looses in the affected part, and is better to erosive type beriberi (tinea pedis) therapeutic effect, relatively poor to blister type treating beri-beri effect.
The object of the present invention is to provide a kind of cure rate height, relapse rate low, have no adverse reaction, thin ointment in the efficient beriberi (tinea pedis) of easy to use, the comprehensive Drug therapy that can be fit to various types of beriberi (tinea pedis) patient.
The present invention is achieved in that thin ointment adopts dispelling wind-evil and wetness-evil in this beriberi (tinea pedis), infiltration is moistened, heat-clearing and toxic substances removing, sterilization and disinfection, thin medicine during blood activating and promoting tissue regeneration is comprehensive, through refining the processing of screening compatibility, in the component and the ratio of thin medicine thick paste be red surplus 6.8-7.3%, Concha Ostreae (calcined) 6.9-7.3%, dried Alumen 10.9-13.9%, forge cream 10.9-13.9%, Calomelas 1.4-3.6%, Borneolum Syntheticum 1.4-3.6%, Camphora 5.8-6.9%, salicylic acid powder 10.9-13.9%, Pulvis Talci 10.9-13.9%, Cornstarch 0-6.6%, Rhizoma Polypodiodis Nipponicae 6.9-7.3%, Oleum Sesami (or glycerol) 13.9-18.2%; In the latting drown liquid medicine component of thin medicine thick paste be the steaming and decocting water of Radix Sophorae Flavescentis, Fructus Cnidii, the Fructus Kochiae, the Radix Angelicae Dahuricae, Radix Glycyrrhizae blend, the component ratio of latting drown liquid medicine is: Radix Sophorae Flavescentis 11.1-12.1%, Fructus Cnidii 4.9-5.6%, Fructus Kochiae 3.6-3.8%, Radix Angelicae Dahuricae 2.4-2.8%, Radix Glycyrrhizae 1.9%, water 75%; Its manufacture method is divided into seven and goes on foot poly-carrying out: the first step, screen various components, and should select the measured medicine of matter as component.In second step, weighing is good in proportion for each component that screening is good.In the 3rd step, Jiang Danyu, Concha Ostreae (calcined), dried Alumen, to forge seven kinds of solid-state drugs mills of cream, Borneolum Syntheticum, Camphora, Rhizoma Polypodiodis Nipponicae superfine, and mix with salicylic acid powder, Pulvis Talci, three kinds of powder attitudes of Cornstarch medicine.In the 4th step, add Oleum Sesami (or glycerol) stirring and mix well into thick paste.The 5th step, will screen load weighted Radix Sophorae Flavescentis, Fructus Cnidii, the Fructus Kochiae, the Radix Angelicae Dahuricae, Radix Glycyrrhizae and put into pot and add the water steaming and decocting back of boiling and continue 20-35 minute, make latting drown liquid medicine after filtration.In the 6th step, thick paste is caused pasty state with cooling back latting drown liquid medicine latting drown.In the 7th step, pack is sealed and is finished product.
Advantage of the present invention: compare with the beriberi of present application, not only have pain relieving, itching relieving advantage, but also have nontoxic, have no adverse reaction, advantage such as safe ready, instant effect, cure rate height, relapse rate are low, simultaneously, the no any cicatrix in back more.
The using method of thin ointment is in this beriberi (tinea pedis): clean foot earlier, dip in ointment with absorbent cotton and smear the affected part equably, every day two to three times is till recovery from illness.Prove through clinical application for many years, to suffering from the patient of blister type, erosive type, phosphorus bits type beriberi, effective percentage is 99.5%, cure rate 95%, morbidity 3 years with interior patient, promptly healed in general medication 1-2 days, promptly healed in the general medication 5-7 of patient days of morbidity 4-9, the patient of morbidity more than 10 years promptly healed in general medication 10-15 days.
Embodiment 1
Screen each component.Take by weighing red surplus 5kg, Concha Ostreae (calcined) 5kg, dried Alumen 10kg, forge cream 10kg, Calomelas 1kg, Borneolum Syntheticum 1kg, Camphora 5kg, salicylic acid powder 10kg, Pulvis Talci 10kg, Cornstarch 1kg, Rhizoma Polypodiodis Nipponicae 5kg, Oleum Sesami 10kg, solid-state drug is levigate, mix with powdered drug, reuse Oleum Sesami is stirred into thick paste.Take by weighing Radix Sophorae Flavescentis 50kg, Fructus Cnidii 20kg, Fructus Kochiae 15kg, Radix Angelicae Dahuricae 10kg, Radix Glycyrrhizae 8kg, put into pot and add water 309kg, continuity was 20 minutes after steaming and decocting was boiled, and made latting drown liquid medicine after filtration.After treating the cooling of latting drown liquid medicine, add in the thick paste, stir while adding, till thick paste furnishing pasty state.With the pack of pasty state ointment, packaging seal promptly gets product.
Embodiment 2
Screen each component.Take by weighing red surplus 10kg, Concha Ostreae (calcined) 10kg, dried Alumen 15kg, forge cream 15kg, Calomelas 5kg, Borneolum Syntheticum 5kg, Camphora 8kg, salicylic acid powder 15kg, Pulvis Talci 15kg, Cornstarch 9kg, Rhizoma Polypodiodis Nipponicae 10kg, Oleum Sesami 20kg, solid-state drug is ground superfine, mix with powdered drug, reuse Oleum Sesami mixes into thick paste.Take by weighing Radix Sophorae Flavescentis 60kg, Fructus Cnidii 30kg, Fructus Kochiae 20kg, Radix Angelicae Dahuricae 15kg, Radix Glycyrrhizae 10kg, put into pot and add water 405kg, continuity was 30 minutes after steaming and decocting was boiled, make latting drown liquid medicine after filtration, treat latting drown liquid medicine cooling after, add in the thick paste, stir while adding, thick paste is transferred to pasty state till.Pack packaging seal then and get finished product.
Embodiment 3
Screen each component.Take by weighing red surplus 8kg, Concha Ostreae (calcined) 8kg, dried Alumen 12kg, forge cream 12kg, Calomelas 3kg Borneolum Syntheticum 3kg, Camphora 7kg, salicylic acid powder 12kg, Pulvis Talci 12kg, Cornstarch 5kg, Rhizoma Polypodiodis Nipponicae 8kg, glycerol 20kg, solid-state drug is ground superfine, mix with powdered drug, reuse glycerol is stirred into thick paste.Take by weighing Radix Sophorae Flavescentis 55kg, Fructus Cnidii 25kg, Fructus Kochiae 18kg, Radix Angelicae Dahuricae 12kg, Radix Glycyrrhizae 9kg, put into pot and add water 357kg, steaming and decocting is boiled and is continued 35 minutes, makes latting drown liquid medicine after filtration.After treating the cooling of latting drown liquid medicine, add in the thick paste, stir while adding, till thick paste furnishing pasty state.Refill bag packaging seal and promptly get product.
Thin ointment is not only applicable to beriberi (tinea pedis) patient in being somebody's turn to do, and also can be used for the tinea manuum, tinea corporis, tinea cruris, tinea versicolor patient.
Claims (3)
1. thin ointment in the efficient beriberi (tinea pedis), adopt dispelling wind-evil and wetness-evil, infiltration is moistened, heat-clearing and toxic substances removing, sterilization and disinfection, thin medicine during blood activating and promoting tissue regeneration is comprehensive, through the screening compatibility, refining processing, thin medicine thick paste component and ratio are in it is characterized in that: red surplus 6.8-7.3%, Concha Ostreae (calcined) 6.9-7.3%, dried Alumen 10.9-13.9%, forge cream 10.9-13.9%, Calomelas 1.4-3.6%, Borneolum Syntheticum 1.4-3.6%, Camphora 5.8-6.9%, salicylic acid powder 10.9-13.9%, Pulvis Talci 10.9-13.9%, Cornstarch 0-6.6%, Rhizoma Polypodiodis Nipponicae 6.9-7.3%, Oleum Sesami (or glycerol) 13.9-18.2%; In thin medicine thick paste latting drown liquid medicine component and ratio be: Radix Sophorae Flavescentis 11.1-12.1%, Fructus Cnidii 4.9-5.6%, Fructus Kochiae 3.6-3.8%, Radix Angelicae Dahuricae 2.4-2.8%, Radix Glycyrrhizae 1.9%, water 75%; Will in thin medicine thick paste add latting drown liquid medicine thick rare be pasty state.
2. according to thin ointment in claims 1 described efficient beriberi (tinea pedis), it is characterized in that manufacture method is: need pellet is surplus, Concha Ostreae (calcined), dried Alumen, forge cream, Borneolum Syntheticum, Camphora, seven kinds of solid-state drugs mills of Rhizoma Polypodiodis Nipponicae is superfine, and mix with salicylic acid powder, Pulvis Talci, three kinds of powdered drugs of Cornstarch, add Oleum Sesami (or glycerol) again and stir into thick paste, add latting drown liquid medicine at last and stir the furnishing pasty state.
3. thin ointment in the efficient beriberi according to claim 1 and 2 (tinea pedis), it is characterized in that latting drown liquid medicine is produced puts into pot for Radix Sophorae Flavescentis, Fructus Cnidii, the Fructus Kochiae, the Radix Angelicae Dahuricae, the Radix Glycyrrhizae that will take by weighing and adds water, steaming and decocting was boiled the back continuity after 20-35 minute, obtained after filtration.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98110520A CN1073851C (en) | 1998-10-23 | 1998-10-23 | High efficiency ointment for curing beri-beri (tinea pedis) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98110520A CN1073851C (en) | 1998-10-23 | 1998-10-23 | High efficiency ointment for curing beri-beri (tinea pedis) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1212162A true CN1212162A (en) | 1999-03-31 |
| CN1073851C CN1073851C (en) | 2001-10-31 |
Family
ID=5220560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN98110520A Expired - Fee Related CN1073851C (en) | 1998-10-23 | 1998-10-23 | High efficiency ointment for curing beri-beri (tinea pedis) |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1073851C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101385775B (en) * | 2007-09-12 | 2011-01-19 | 高桂荣 | Medicine for treating tinea pedis and preparation method thereof |
| CN102228476A (en) * | 2011-06-16 | 2011-11-02 | 金喜荣 | Medicament for treating beriberi and technological process thereof |
| CN104906203A (en) * | 2015-04-24 | 2015-09-16 | 南通蛇类治疗研究所 | Tinea manus and pedis treatment painless nano emulsifiable paste |
| CN107184817A (en) * | 2017-06-11 | 2017-09-22 | 李宝 | The ointment that a kind of tinea pedis patient at night is used |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104055789A (en) * | 2014-06-04 | 2014-09-24 | 訾路 | Medicine for treating beriberi |
-
1998
- 1998-10-23 CN CN98110520A patent/CN1073851C/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101385775B (en) * | 2007-09-12 | 2011-01-19 | 高桂荣 | Medicine for treating tinea pedis and preparation method thereof |
| CN102228476A (en) * | 2011-06-16 | 2011-11-02 | 金喜荣 | Medicament for treating beriberi and technological process thereof |
| CN102228476B (en) * | 2011-06-16 | 2012-09-19 | 金喜荣 | A kind of medicine for treating beriberi and its technical method |
| CN104906203A (en) * | 2015-04-24 | 2015-09-16 | 南通蛇类治疗研究所 | Tinea manus and pedis treatment painless nano emulsifiable paste |
| CN107184817A (en) * | 2017-06-11 | 2017-09-22 | 李宝 | The ointment that a kind of tinea pedis patient at night is used |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1073851C (en) | 2001-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101297889B (en) | Chinese medicine preparation for treating foot-and-mouth disease and preparation method thereof | |
| CN102727815B (en) | Oral liquid for stopping diarrhea and strengthening stomach | |
| CN1073851C (en) | High efficiency ointment for curing beri-beri (tinea pedis) | |
| KR102473731B1 (en) | Manufacturing method for detoxification pill | |
| CN101703714B (en) | Chinese medicinal medicament for treating acute glomerulonephritis | |
| CN1381265A (en) | Medicine for treating cholecystitis and its preparing process | |
| CN102283981A (en) | Drug for curing hyperthyroidism and preparation method thereof | |
| CN1114437C (en) | Male Yang tonifying wine | |
| CN106390060A (en) | Health preserving foot patch and processing technology thereof | |
| CN112245526A (en) | A kind of health care wine containing black snake and its preparation method and application | |
| CN1085536C (en) | Medicinal vinegar for curing rheumatism and rheumatoid and preparation process thereof | |
| CN109394901A (en) | A kind of agalloch eaglewood surprise nanmu wine and preparation method and applications | |
| CN109718356A (en) | A kind of Chinese medicine composition for treating stomach asthenic type anaemia | |
| CN102038896A (en) | Chinese medicinal preparation for treating lung deficiency trachitis | |
| CN1165322C (en) | Medicine for curing gastritis, gastric and duodenal ulcer | |
| CN1080520A (en) | Body peculiar smell removing pill | |
| WO2017084169A1 (en) | Medicinal liquor for nourishing stomach and preparation method therefor | |
| CN1333039A (en) | Poria repercussion powder medicine | |
| CN103040899B (en) | Traditional Chinese medicine noninvasive-drug for anal fistula and preparation method and use method thereof | |
| CN103007188A (en) | Pharmaceutical composition for treating gallstone | |
| CN109700981A (en) | A kind of Chinese medicine composition for treating the cold anaemia of body | |
| CN109745394A (en) | A kind of Chinese medicine composition for treating the dry wind-heat of blood and pruitus | |
| CN1253006A (en) | Medicinal tea for gastrosis | |
| CN109771555A (en) | A kind of Chinese medicine composition for treating asthenic symptoms edema | |
| CN111297960A (en) | A kind of medicine bag making method with clearing, adjusting and supplementing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |